Cyclic Citrullinated Peptide Ab IgG is a critical reagent for autoimmune research and diagnostic assay development, positioned as a high-specificity biomarker control. This guide details purity specifications exceeding 95% by HPLC, ensuring minimal cross-reactivity and batch-to-batch consistency for reliable immunoassay standardization. Manufacturing follows cGMP guidelines with stringent raw material sourcing from validated peptide synthesis facilities, addressing buyer pain points like lot variability and supply chain instability. Applications include ELISA calibration, lateral flow validation, and multiplex panel optimization. Quality advantages include lyophilized formulation for extended stability, rigorous QC testing for endotoxin and host cell protein removal, and full documentation for regulatory compliance. By prioritizing traceable sourcing and verified purity thresholds, this guide helps procurement teams avoid costly assay failures and ensure reproducible results in clinical research environments.
Target Keyword: cyclic citrullinated peptide ab igg
Cyclic citrullinated peptide ab igg, commonly referred to as anti-CCP IgG antibody, is a critical reagent used in autoimmune research and diagnostic assay development. For B2B buyers—including peptide synthesis companies, diagnostic kit manufacturers, and cosmetic raw material distributors—the core value lies in its high specificity for detecting rheumatoid arthritis (RA) biomarkers. This peptide serves as a gold-standard antigen in ELISA and lateral flow platforms, enabling precise serological analysis. The product is defined by its cyclic structure, which mimics citrullinated epitopes, ensuring robust binding affinity to IgG antibodies in patient samples.
Industry data indicates that the global anti-CCP antibody testing market is projected to grow at a CAGR of 8.2% through 2030, driven by increasing RA prevalence and demand for high-purity cyclic citrullinated peptide ab igg in diagnostic manufacturing.
The production of cyclic citrullinated peptide ab igg follows a rigorous solid-phase peptide synthesis (SPPS) process, utilizing Fmoc chemistry to ensure sequence fidelity. After linear assembly, the peptide undergoes cyclization via disulfide bond formation or head-to-tail amidation, depending on the target epitope. Purification is achieved through preparative reverse-phase HPLC, with real-time UV monitoring at 220 nm and 280 nm. Each batch is then lyophilized under controlled conditions to preserve structural integrity.
Quality control includes multiple orthogonal tests: mass spectrometry (MALDI-TOF) for molecular weight confirmation, analytical HPLC for purity verification, and circular dichroism (CD) spectroscopy to confirm cyclic conformation. Third-party certification from ISO 17025-accredited labs is available upon request, ensuring compliance with global regulatory standards.
Cyclic citrullinated peptide ab igg is primarily utilized in three commercial domains: cosmetic formulation testing, laboratory research, and bulk wholesale distribution. In cosmetic development, this peptide is employed as a positive control in anti-inflammatory assays, helping formulators validate the efficacy of anti-aging ingredients. For lab research, it serves as a key antigen in autoimmune disease studies, enabling accurate detection of RA-specific IgG antibodies in serum samples. Bulk wholesale buyers—such as diagnostic kit manufacturers—integrate the peptide into ELISA kits, lateral flow devices, and multiplex assays, requiring consistent purity and lot-to-lot uniformity.
For example, a typical bulk order of 100 mg cyclic citrullinated peptide ab igg can support the production of 10,000 ELISA test wells, making it a cost-effective solution for high-throughput screening. Additionally, the peptide is used in quality control panels for clinical laboratories, ensuring assay specificity and sensitivity. Its cyclic structure provides enhanced stability compared to linear peptides, reducing degradation during storage and shipping.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 70–85% by HPLC | Higher specificity reduces false positives in assays |
| Cyclic Conformation | Verified by CD spectroscopy | Often linear or poorly cyclized | Improved binding affinity to IgG antibodies |
| Endotoxin Level | <0.1 EU/µg | 0.5–2.0 EU/µg | Safe for cell-based and in vivo studies |
| Batch Consistency | ≤5% variation in HPLC | 10–20% variation | Reliable results across multiple experiments |
| Technical Support | Full CoA and custom synthesis | Limited documentation | Faster troubleshooting and regulatory compliance |
When sourcing cyclic citrullinated peptide ab igg in bulk, buyers must avoid common pitfalls such as accepting low-purity batches that compromise assay accuracy or overlooking endotoxin limits for cell-based applications. A critical selection standard is verifying the cyclic structure through CD spectroscopy or NMR, as linear impurities can reduce binding specificity. Additionally, ensure the supplier provides a detailed Certificate of Analysis (CoA) with HPLC chromatograms and mass spec data.
Buyer checklist for bulk orders: (1) Request a sample batch for in-house validation before full purchase. (2) Confirm storage conditions and shelf life under your logistics chain. (3) Evaluate supplier lead times and minimum order quantities (MOQs). (4) Check for third-party certifications like ISO 9001 or GMP. (5) Negotiate pricing based on volume, with discounts typically available for orders above 1 gram. By following these guidelines, buyers can secure high-quality cyclic citrullinated peptide ab igg that meets rigorous research and manufacturing standards.
The primary advantages of our cyclic citrullinated peptide ab igg include exceptional purity, structural stability, and cost performance. With ≥98% purity by HPLC, the peptide minimizes non-specific binding in diagnostic assays, enhancing signal-to-noise ratios. Its cyclic conformation, verified by CD spectroscopy, ensures consistent epitope presentation, leading to reproducible results across batches. Stability studies demonstrate a shelf life of 24 months at -20°C, reducing waste and inventory turnover costs.
Cost performance is optimized through scalable synthesis processes, allowing competitive pricing for bulk orders without compromising quality. Technical support includes access to custom modifications (e.g., biotinylation or fluorescent tags) and expedited shipping for urgent projects. For B2B clients, we offer volume discounts, flexible payment terms, and dedicated account management, making this peptide a reliable choice for long-term sourcing needs.
Q1: What is the typical purity range for cyclic citrullinated peptide ab igg used in diagnostic kit manufacturing?
A1: For diagnostic kit manufacturing, a purity of ≥98% by HPLC is standard, with premium grades at ≥99% for high-sensitivity assays. Lower purity can lead to false positives due to truncated or misfolded peptide fragments.
Q2: How should cyclic citrullinated peptide ab igg be stored to maintain stability during bulk shipping?
A2: The lyophilized peptide should be stored at -20°C in a desiccated environment. For shipping, use insulated containers with dry ice to maintain temperature stability. Reconstituted solutions must be used within 7 days when stored at 4°C.
Q3: Can cyclic citrullinated peptide ab igg be customized with modifications like biotin or fluorescent labels?
A3: Yes, custom modifications are available, including biotinylation, FITC labeling, and PEGylation. These modifications require additional synthesis steps and quality control, but they enable specific applications in multiplex assays and imaging studies.